Enzalutamide in patients with castration-resistant prostate cancer: retrospective, multicenter, real life study.

CONCLUSIONS: Our data shows an effective and safe profile of enzalutamide in a "realworld" perspective in patients with mcRPC. PMID: 32748613 [PubMed - as supplied by publisher]
Source: Minerva Urologica e Nefrologica - Category: Urology & Nephrology Tags: Minerva Urol Nefrol Source Type: research